13 June 2010
Can Alzheimer’s Disease Be Prevented? Researchers Explore Potential Interventions in a Special Issue of the Journal of Alzheimer’s Disease
Amsterdam, The Netherlands – Although effective treatment for Alzheimer’s disease (AD) has been slow to emerge, there has been substantial progress in identifying AD risk factors and developing treatments that might delay or prevent onset of the disease.
24 May 2010
Rudy J. Castellani, Jr., MD, has been chosen as recipient of the 2010 Alzheimer Award presented by the Journal of Alzheimer’s Disease in recognition of his outstanding work, “Reexamining Alzheimer’s Disease: Evidence for a Protective Role for Amyloid-β Protein Precursor and Amyloid-β” (J Alzheimers Dis 18, 447-452, 2009) by R.J. Castellani et al.
23 May 2010
Alcohol Consumption May Protect Against Risk of Alzheimer’s Disease, Particularly in Female Nonsmokers
A new study published this month in the Journal of Alzheimer's Disease suggests a protective effect of alcohol consumption on the risk of Alzheimer's disease, particularly in women who do not smoke.
16 May 2010
New Evidence Caffeine May Slow Alzheimer’s Disease and Other Dementias and Restore Cognitive Function
Amsterdam, The Netherlands –Although caffeine is the most widely consumed psychoactive drug worldwide, its potential beneficial effect for maintenance of proper brain functioning has only recently begun to be adequately appreciated.
19 April 2010
Amsterdam, The Netherlands – Alzheimer's disease (AD) is a neurodegenerative disorder affecting millions of people worldwide and has become a major global concern. Uncontrolled oligomerization (aggregation) of Aβ peptide is the hallmark of AD and it is believed to be causally related to AD pat
18 April 2010
According to a new analysis of the performance of a drug developed by the Mental Health Research Institute in partnership with Prana Biotechnology the drug is even more effective in reversing dementia symptoms than previously believed.
28 March 2010
Montreal, Cananda –Prof. Claudio Cuello at McGill University and his collaborators have genetically manipulated rats that can emulate Alzheimer’s disease in humans, enabling research that will include the development of new treatments.
15 March 2010
Madrid, Spain –The use of repetitive anesthesia with isoflurane (one of the most common anesthetics by inhalation) increases the risk of developing changes similar to those observed in AD brains in mice with mutations of the amyloid precursor protein (APP).
10 March 2010
Knoxville, TN – Early detection is key to more effective treatment for Alzheimer's disease and other forms of cognitive impairment, and new research shows that a test developed at the University of Tennessee is more than 95 percent effective in detecting cognitive abnormalities associated wit
28 February 2010
Artificial Neural Networks Help Identify Predisposing Factors for Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
Amsterdam – Mild cognitive impairment (MCI) is often considered an early symptom of Alzheimer’s disease (AD). An analysis of genetic risk factors predisposing to MCI is critical for accessing individual predisposition and reliably evaluating the effectiveness of early treatment.